A G155E-mutated H1N1 strain is driving an early U.S. flu surge. Early data suggest the updated vaccine still offers ...

From a new flu variant and rising workplace insurance costs, here are the top health stories for Thursday, Oct. 22, 2026.

Flu season is picking up months ahead of schedule with a mutated virus spreading in some parts of the United States.

From Stratus to Cicada, several variants are on the radar as COVID-19 activity rises, impacting how the virus spreads, its ...

This year's flu season started weeks sooner than usual and a new variant of H1N1 is the main culprit.

France has reported the first documented human case of Shamonda virus, previously associated with livestock. The fatal infection raises questions about transmission, immune vulnerability and potential ...

A livestock virus that was first detected in Europe this summer can infect humans as well, confounding scientists’ ...

Although the case is considered exceptional, investigators are working to determine how the infection occurred and whether the pathogen played a role in the patient’s death. France confirmed the death ...

SEATTLE, Sept. 23, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced an expansion of its multi-year research collaboration and license agreement with ...

N/A Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Boehringer is no stranger to the cardiovascular space, marketing the heart failure and chronic kidney disease drug Jardiance, the blood thinner Pradaxa and the hypertension drug Twynsta, among others.